Cite
MLA Citation
Jason Lickliter et al.. “Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β-lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β-lactamases.” Open forum infectious diseases, vol. 4, n.d., p. S524. http://access.bl.uk/ark:/81055/vdc_100151518780.0x000038